MDsave Launches Discounted Mammogram Campaign
MDsave, the healthcare services platform connecting providers, employers, and patients to transactable healthcare, has launched its annual campaign to reduce the cost of 2D and 3D screening mammograms.
Category: Mammography
Mammography
Latest
Mammography
Latest
MITA Urges USPSTF to Enhance Breast Cancer Screening Guidelines
The Medical Imaging & Technology Alliance (MITA) has submitted comments to United States Preventive Services Task Force on its draft recommendation on breast cancer screening.
Mammography
Latest
First Patients Enrolled in Contrast-Enhanced Mammography Imaging Screening Trial
The Contrast-Enhanced Mammography Imaging Screening Trial, a clinical trial to determine if contrast-enhanced mammography improves breast cancer detection and reduces false-positive exams in women with dense breasts, has enrolled its first patients.
Breast Cancer Risk Models May Incorrectly Classify Many Women
Breast cancer risk estimates for individual women vary substantially depending on which risk assessment model is used, and women are likely receiving vastly different recommendations depending on the model used and the cutoff applied to define “high risk.”
Read More
Uncertainty about Breast Cancer Risk Heighten with Breast Density Awareness
Awareness of breast density appears to increase one’s perceived breast cancer risk for a short time after undergoing mammography, according to a new study.
Read More
Clinical Factors Associated with Background Parenchymal Enhancement on Contrast-Enhanced Mammography
According to a new study, both menstrual status and menstrual cycle time are associated with the degree of early background parenchymal enhancement on contrast-enhanced mammography (CEM), which could influence CEM interpretations.
Read More
Imago OA/US Breast Imaging System May Help Reduce Biopsies of Benign Breast Masses
A retrospective study of Seno Medical’s Imagio Breast Imaging System found that the company’s opto-acoustic/ultrasound technology significantly improves specificity at fixed sensitivity compared to conventional ultrasound.
Read More
U.S. FDA Clears MedCognetics’ AI-Enabled Breast Cancer Screening Software
Digital health company MedCognetics, Inc. announces that it has received U.S. FDA 510(k) clearance of its artificial intelligence-enabled software for breast cancer screening, QmTRIAGE.
Read More